Table 2 Baseline Characteristics
Characteristics | Overall (n = 163) | Tertile-1 (n = 54) | Tertile-2 (n = 55) | Tertile-3 (n = 54) | P-value |
|---|---|---|---|---|---|
Age (years) | 60 ± 13 | 60 ± 14 | 57 ± 14 | 63 ± 11 | 0.054 |
Male Gender n, (%) | 120 (74) | 40 (74) | 39 (71) | 41 (76) | 0.835 |
FH for CAD n, (%) | 19 (12) | 9 (17) | 6 (11) | 4 (7) | 0.318 |
Diabetes n, (%) | 24 (15) | 7 (13) | 5 (9) | 12 (22) | 0.139 |
Hypertension n (%) | 90 (55) | 27 (50) | 28 (51) | 35 (65) | 0.219 |
Hypercholesterolemia n, (%) | 92 (53) | 30 (56) | 33 (60) | 29 (54) | 0.658 |
Active Smoking n, (%) | 66 (40) | 20 (37) | 26 (47) | 20 (37) | 0.453 |
Prodromal Angina n. (%) | 55 (34) | 19 (35) | 20 (36) | 16 (30) | 0.731 |
Time-to-PPCI (min) | 195 (128–270) | 209 (129–270) | 173 (125–208) | 197 (149–303) | 0.111 |
Systolic blood pressure (mmHg) | 119 ± 21 | 124 ± 22 | 120 ± 21 | 114 ± 20 | 0.061 |
Diastolic blood pressure (mmHg) | 70 ± 14 | 71 ± 15 | 72 ± 14 | 68 ± 13 | 0.368 |
Heart Rate (bpm) | 75 ± 16 | 74 ± 14 | 73 ± 15 | 78 ± 19 | 0.165 |
RPP before PPCI (mmHg∙bpm) | 9032 ± 2713 | 9296 ± 2780 | 8779 ± 2547 | 9027 ± 2831 | 0.613 |
Infarct related artery n, (%) | 0.537 | ||||
LAD | 74 (45) | 28 (52) | 23 (42) | 23 (43) | |
RCA | 62 (38) | 17 (31) | 25 (46) | 20 (37) | |
LCX | 27 (17) | 9 (17) | 7 (13) | 11 (20) | |
Anterior Infarction n, (%) | 74 (45) | 28 (52) | 23 (41) | 23 (43) | 0.506 |
Non-IRA critical stenosis n, (%) | 0.865 | ||||
0 | 79 (49) | 28 (52) | 28 (51) | 23 (43) | |
1 | 51 (31) | 15 (25) | 17 (31) | 19 (35) | |
2 | 33 (20) | 11 (20) | 10 (18) | 12 (22) | |
TIMI flow-grade pre-PPCI n, (%) | 0.237 | ||||
0,1 | 121 (74) | 40(74) | 37 (67) | 44 (82) | |
2,3 | 42 (26) | 14 (26) | 18 (33) | 10 (19) | |
TIMI flow-grade post-PPCI n, (%) | 0.444 | ||||
0,1 | 2 (1) | 0(0) | 1 (2) | 1 (2) | |
2,3 | 161 (99) | 54 (100) | 54 (98) | 53 (98) | |
Rentrop flow-grade n, (%) | 0.152 | ||||
0,1 | 152 (93) | 53 (98) | 50 (91) | 49 (91) | |
2,3 | 11 (7) | 1 (2) | 5 (9) | 5 (9) | |
Medication at discharge | |||||
ACEi or ARBs n, (%) | 160 (98) | 53 (98) | 53 (96) | 54 (100) | 0.369 |
Beta-blockers n, (%) | 126 (77) | 39 (72) | 44 (80) | 43 (80) | 0.552 |
Statins n, (%) | 154 (95) | 51 (94) | 54 (98) | 53 (98) | 0.458 |
Diuretics n, (%) | 13 (8) | 2 (4) | 4 (7) | 7 (13) | 0.197 |